Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cells
Semih U. Tareen(Metis Design Corporation (United States)), Peter Berglund, Christopher J. Nicolai(Metis Design Corporation (United States)), Neal Van Hoeven(Sana Biotechnology (United States)), Brenna Kelley-Clarke(Metis Design Corporation (United States)), Megan M. Slough(Metis Design Corporation (United States)), Chintan D. Vin(Metis Design Corporation (United States)), Scott H. Robbins(TRIA Bioscience (United States)), Jan H. ter Meulen
Cited by 0
Related Papers
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
|Proceedings of the National Academy of Sciences|2008|198
The <i>Mx1</i> Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses
|Journal of Virology|2007|182